Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Northern Mariana Islands
Northern Mariana Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.6% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Northern Mariana Islands, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Northern Mariana Islands recorded 0.6% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 53.8% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Northern Mariana Islands peaked at 1.3% in 2015 and was at its lowest, 0.6%, in 2022.
That places Northern Mariana Islands 50th out of 215 countries with data for 2024, putting it in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Northern Mariana Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.3% | — |
| 2016 | 1.2% | -7.7% |
| 2017 | 1.2% | +0.0% |
| 2018 | 1.1% | -8.3% |
| 2019 | 1.0% | -9.1% |
| 2020 | 0.8% | -20.0% |
| 2021 | 0.7% | -12.5% |
| 2022 | 0.6% | -14.3% |
| 2023 | 0.6% | +0.0% |
| 2024 | 0.6% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.2% | 1.0% | 1.3% | 5 |
| 2020s | 0.7% | 0.6% | 0.8% | 5 |
Countries ranked near Northern Mariana Islands
More development goals data for Northern Mariana Islands
- Red List Index 0.6073 (2025)
- Number of refugees per 100,000 population, by country of origin 0 (2025)
- Number of transboundary breeds 12 (2025)
- Number of transboundary breeds (not extinct) 12 (2025)
- Number of transboundary breeds with unknown risk status 12 (2025)
- Number of local breeds with unknown risk status 1 (2025)
- Number of local breeds (not extinct) 1 (2025)
- Number of local breeds kept in the country 1 (2025)
- Domestic material consumption, by type of raw material 493.89 (2024)
- DEC alternative conversion factor 1 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Northern Mariana Islands?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Northern Mariana Islands was 0.6% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Northern Mariana Islands?
- The highest recorded value was 1.3% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Northern Mariana Islands?
- The lowest recorded value was 0.6% in 2022.
- How does Northern Mariana Islands rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Northern Mariana Islands ranks 50th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Northern Mariana Islands?
- Over the last ten years it is down 53.8%. The long-run trend across the full record is falling.
- Where does this Northern Mariana Islands data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).